Skip to main content

Stomach Cancer News

Related terms: Cancer, Gastric, Cancer, Stomach, Gastric Carcinoma

FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin

March 11, 2019 - Pfizer Inc. today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Trazimera (trastuzumab-qyyp), a biosimilar to Herceptin® (trastuzumab),1 for the ...

FDA Approves Ogivri (trastuzumab-dkst), a Biosimilar to Herceptin

December 1, 2017 – The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic...

FDA Approves Cyramza (ramucirumab) in Combination with Paclitaxel for Advanced Gastric Cancer after Prior Chemotherapy

INDIANAPOLIS, Nov. 5, 2014 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab) in combination with...

FDA Approves Cyramza for Stomach Cancer

April 21, 2014 – The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cancer

Related drug support groups

fluorouracil, Opdivo